Securities code: 000710 securities abbreviation: Berry Genomics Co.Ltd(000710) Announcement No.: 2022-015 Berry Genomics Co.Ltd(000710)
Announcement on the expiration of the implementation period and implementation results of the shareholding reduction plan of 5% shareholders
Tianjin junruiqi equity investment partnership (limited partnership), a shareholder holding more than 5%, guarantees that the information provided to the company is true, accurate and complete without false records, misleading statements or major omissions. The company and all members of the board of directors guarantee that the contents of the announcement are consistent with the information provided by the information disclosure obligor. Special tips:
Berry Genomics Co.Ltd(000710) (hereinafter referred to as “the company”) disclosed the pre disclosure announcement on the reduction of shares held by shareholders holding more than 5% (Announcement No.: 2021-074) on November 4, 2021: the shareholder of the company, Tianjin junruiqi equity investment partnership (limited partnership) (hereinafter referred to as “junruiqi”), plans to start from November 25, 2021 (inclusive) to February 24, 2022 (inclusive) During the period, the company’s shares will be reduced by means of centralized bidding transaction to no more than 3546000 shares (accounting for about 1.00% of the total share capital of the company), and it is planned to reduce the company’s shares by means of block transaction to no more than 7092100 shares (accounting for about 2.00% of the total share capital of the company) from November 9, 2021 to February 8, 2022, The total reduction of the above holdings shall not exceed 10638100 shares (accounting for about 3.00% of the total share capital of the company) (hereinafter referred to as the “reduction plan”).
Recently, the company received the notification letter of Tianjin junruiqi equity investment partnership (limited partnership) on the results of share reduction: during the period of this reduction plan, junruiqi has reduced 3948000 shares of the company, accounting for about 1.11% of the total share capital of the company. The implementation period of this reduction plan expires (hereinafter referred to as “this reduction”).
1、 Shareholder reduction
1. Share reduction by shareholders
Average price of reduction number of shares reduced proportion of reduction (%)
Shareholder’s name reduction method during the reduction period (yuan / share) (10000 shares) accounting for the total share capital accounting for the total number of the reduction plan
Centralized bidding delivery: 2021.11.25 – 21.22 350.8000 0.99 32.98
Junruiqiyi 2022.2.24
Block transaction 2021.11.9-20 21.06 44.0000 0.12 4.14
22.2.8
-Total — 394.8000 1.11 37.12
Junruiqi’s reduction of shares comes from the new shares of the company obtained by subscribing for the equity of Beirui Hekang in the transaction of issuing shares to purchase 100% equity of Beijing beiruihekang Biotechnology Co., Ltd. (hereinafter referred to as “beiruihekang”) and selling major assets. Junruiqi’s reduction price range through centralized bidding transaction is 17.13 yuan / share – 24.46 yuan / share.
2. Shareholding before and after this reduction
Shares held by shareholders before this reduction and shares held after this reduction
Name share nature share number in total share capital share number in total share capital
(10000 shares) cases (%) (10000 shares) cases (%)
Total shares held 1773.0261 5.00 1378.2261 3.89
Junruiqi, including: shares with unlimited sales conditions 1773.0261 5.00 1378.2261 3.89
Shares with limited sales conditions —-
2、 Other relevant instructions
1. Junruiqi’s share reduction strictly complies with the company law, the stock listing rules of Shenzhen Stock Exchange (revised in 2022), the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange and other relevant laws There is no violation of the provisions of laws, regulations and business rules on share transfer.
2. Junruiqi’s reduction is consistent with the disclosed reduction plan, and there is no violation. Junruiqi implements this reduction within the time range and quantity listed in the reduction plan. There is no reduction of shares after the expiration of the reduction period, nor does the reduction exceed the specified amount.
3. Junruiqi is not the controlling shareholder and actual controller of the company. This reduction will not lead to the change of the company’s control right and will not affect the company’s governance structure and sustainable production and operation.
4. After this reduction, junruiqi will no longer be a major shareholder of the company. Its shares are still specific shares and will still comply with the relevant restrictive provisions on share changes such as the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange.
3、 Documents for future reference
1. The notification letter of Tianjin junruiqi equity investment partnership (limited partnership) on the result of share reduction is hereby announced.
Berry Genomics Co.Ltd(000710) board of directors February 25, 2022
